Upstream Bioprocessing Market Size, Trends And Overview Report 2024-2033

Global upstream bioprocessing market size is expected to reach $19.84 Bn by 2028 at a rate of 13.3%, segmented as by product type, bioreactors, fermenters, cell culture media, filters, bags and containers

Jul 23, 2024 - 12:21

0 3

Upstream Bioprocessing Market Size, Trends And Overview Report 2024-2033

The upstream bioprocessing global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Upstream Bioprocessing Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size -

The upstream bioprocessing market size has grown rapidly in recent years. It will grow from $10.63 billion in 2023 to $12.03 billion in 2024 at a compound annual growth rate (CAGR) of 13.1%. The growth in the historic period can be attributed to rise in need for process optimization and contamination free, safe and efficient production of biomolecules, commercial success and rising demand for bio-therapeutics, rise in the implementation of process analytical technology, rise in chronic disease prevalence, and increased research into the production of biosimilar.

The upstream bioprocessing market size is expected to see rapid growth in the next few years. It will grow to $19.84 billion in 2028 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to commercial use of single-use bioreactors, outsourcing of biopharmaceutical manufacturing, rapid growth of pharmaceutical and biotechnology industries, rising adoption of single-use upstream bioprocessing, and increasing partnerships, mergers, acquisitions, and collaborations. Major trends in the forecast period include increasing investments in r&d in biopharmaceutical industry, technological advancements, advanced upstream bioprocessing technologies, development of new technologies and advanced filtration technologies.

Order your report now for swift delivery @ https://www.thebusinessresearchcompany.com/report/upstream-bioprocessing-global-market-report

Scope Of Upstream Bioprocessing Market

The Business Research Company's reports encompass a wide range of information, including:

Market Size (Historic and Forecast): Analysis of the market's historical performance and projections for future growth.
Drivers: Examination of the key factors propelling market growth.
Trends: Identification of emerging trends and patterns shaping the market landscape.
Key Segments: Breakdown of the market into its primary segments and their respective performance.
Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
Macro Economic Factors: Assessment of broader economic elements impacting the market.

Upstream Bioprocessing Market Overview

Market Drivers -

Market Trends -

Major companies operating in the upstream bioprocessing market are focused on developing advanced bioreactors to meet the needs of cell culture processes that enhance performance, flexibility, and scalability. Bioreactors are essential tools in upstream bioprocessing, enabling the efficient and controlled production of biopharmaceuticals through cell culture and biomolecule production. For instance, in April 2023, Cytiva, a US-based provider of life sciences products and solutions, introduced X-platform bioreactors designed to streamline single-use upstream bioprocessing procedures. The bioreactors consist of a tank, cabinet assembly, and human-machine interface (HMI). This modular design allows flexible arrangements without custom hardware or single-use bags. User-friendly features include an optimized vessel with a full-opening door, baffles, and improved cable management. Additionally, the online Bioreactor Scaler tool helps determine optimal parameters for successful scale-up.

The upstream bioprocessing market covered in this report is segmented –

1) By Product type: Bioreactors, Fermenters, Cell Culture Media, Filters, Bags And Containers

2) By Workflow: Media Preparation, Cell Culture, Cell Separation

3) By Usage type: Single-Use, Multi-Use

4) By Mode: In House, Outsourced

5) By End User: Contract Development and Manufacturing Organization (CDMOs) Or Contract Research Organization (CROs), Research And Academic Institutes, Biopharmaceutical Companies

Get an inside scoop of the upstream bioprocessing market, Request now for Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=15950&type=smp

Regional Insights -

North America was the largest region in the upstream bioprocessing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the upstream bioprocessing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Key Companies -

Major companies operating in the upstream bioprocessing market are Thermo Fisher Scientific Inc., Danaher Corp, Merck KGaA, GE HealthCare Technologies, Parker Hannifin Corp, Corning Inc., AGC Biologics, Avantor, AGC Inc., Boehringer Ingelheim International GmbH, Catalent Inc., Sartorius AG, Entegris Inc., Getinge AB, Bio-Rad Laboratories Inc., Samsung Biologics Co. Ltd., Eppendorf AG, Repligen Corporation, Takara Bio Inc., KBI Biopharma Inc., Rentschler Biopharma SE, Just Biotherapeutics Inc., PBS Biotech Inc., Stobbe Group, Applikon Biotechnology

Table of Contents